HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wiktor, T. J. Articles by Koprowski, H. Search for Related Content PubMed PubMed Citation Articles by Wiktor, T. J. Articles by Koprowski, H.

Cultivation of Rabies Virus in Human Diploid Cell Strain WI-38¹

From The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania

Abstract

In spite of the initial infectivity of three strains of rabies virus for the human diploid cell strain WI-38, the virus could not be serially propagated in this cell system with conventional methods of passaging infectious material. However, by following the mixing-cell transfer technique, three strains could finally be adapted so that they could propagate indefinitely. The adapted HEP virus caused a cytopathic effect in WI-38 and its infectivity, for four other tissue culture systems of different animal origins increased during the course of its propagation in WI-38.

After adaptation to WI-38, the HEP strain seemed to lose its lethal properties for monkeys injected intracerebrally, while acquiring a high degree of immunizing capacity for the same species.

Inactivated vaccines prepared from two other strains of fixed virus (CVS and PM) were found to be highly antigenic after adaptation to WI-38. This fact and the availability of the WI-38-adapted live HEP virus seem to indicate that production of effective and safe anti-rabies vaccine for man is now feasible.

Finally, because of good antigenic properties demonstrated either by the live attenuated HEP virus or by inactivated CVS and PM viruses grown in WI-38, an ideal medium for the production of human vaccines, effective and safe immunization of man against rabies may not be too far away.

Footnotes

¹ This work was supported, in part, by United States Public Health Service Grant AI-02954 from the National Institute of Allergy and Infectious Diseases and by the World Health Organization.

This article has been cited by other articles:

				R.B. Heath Human Disease and Vaccination The Journal of the Royal Society for the Promotion of Health, August 1, 1976; 96(4): 160 - 163.